Infection-Related Malignant Neoplasm — Trials

Infection-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 133
Recruiting: 71
Ph III recruiting: 2
Growth YoY: −24%
Industry share: 17%
Top sponsor: National Cancer Institute (NCI)
Termination share: 30.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (75)

clinicaltrialsPublishedShowing 51–53 of 53 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00704691	Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas	terminated	Early Phase 1	1	University of Alabama at BirminghamOTHER	1	Apr 20, 2012	clinicaltrials
NCT01116154	Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma	terminated	Phase 1	30	City of Hope Medical CenterOTHER	1	Dec 9, 2010	clinicaltrials